Biovail US SEC false statement case to go to trial
This article was originally published in Scrip
Executive Summary
A federal judge has denied partial summary judgement to the US Securities and Exchange Commission in a case regarding three former Biovail executives and alleged securities violations, and has ruled that there are issues for a jury to decide. In the case, the SEC charged in part that former CEO Eugene Melnyk, former chief financial officer Brian Crombie and ex-controller John Miszuk made false or misleading statements to investors.